Willingness to pay for hepatitis B vaccination in Selangor, Malaysia: A cross-sectional household survey

Rajamoorthy, Yogambigai; Radam, Alias; Taib, Niazlin Mohd; Rahim, Khalid Abdul; Munusamy, Subramaniam; Wagner, Abram L.; Mudatsir, Mudatsir; Bazrbachi, Abdullatif; Harapan, Harapan

doi:10.1371/journal.pone.0215125

Cited by 52 publications

(63 citation statements)

References 62 publications

(67 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One important finding is that those who had a higher perceived risk to be infected with COVID-19 were more likely to accept the vaccine, but only for the 95% effective vaccine. Previous studies in Asia have found that perceived risk or perceived susceptibility to an infection is associated with positive support for vaccination (29,30,39). Another study also found that high perceived risk was associated with COVID-19 vaccine acceptance among general community members in Saudi Arabia (40) and among HCWs in China (41).…”

Section: Discussionmentioning

confidence: 88%

“…In the region of southeast Asia, studies have been conducted to assess the acceptance of a vaccine against infectious diseases (21)(22)(23)(24)(25)(26)34). This present study was conducted to understand how the COVID-19 vaccine, when available, will be accepted by the general population in Indonesia, by asking individuals about a hypothetical vaccine-an approach used in many past studies (21,26,(28)(29)(30). Understanding vaccine acceptance in Indonesia is important, given the large population and because the country has relatively high vaccine hesitancy for existing vaccines and relatively low vaccination coverage (18,19).…”

Section: Discussionmentioning

confidence: 99%

“…Currently no COVID-19 vaccine is available and therefore we framed the study questions around a hypothetical vaccine, in an approach that was similar to previous studies ( 21 , 26 , 28 – 30 ). Due to limitations in doing face-to-face research during the current active COVID-19 outbreak in Indonesia, we did an online cross-sectional study between March 25 and April 6, 2020.…”

Section: Methodsmentioning

confidence: 99%

See 2 more Smart Citations

Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia

Harapan

Wagner

Yufika

et al. 2020

Front. Public Health

Self Cite

578

558

View full text Add to dashboard Cite

Introduction: Several vaccine candidates are being clinically tested in response to the 2019 coronavirus disease (COVID-19) pandemic. This study was conducted to assess the acceptance of a 50 or 95% effective COVID-19 vaccine, when it becomes available in southeast Asia, among the general population in Indonesia. Methods: A cross-sectional online survey was conducted between March 25 and April 6, 2020. Participants were asked if they would accept a free vaccine which was 95 or 50% effective. Using a logistic regression model, we assessed the associations between sociodemographic characteristics, exposure to COVID-19 information, or perceived risk of infection with acceptance of a hypothetical COVID-19 vaccine. Results: Among 1,359 respondents, 93.3% of respondents (1,268/1,359) would like to be vaccinated for a 95% effective vaccine, but this acceptance decreased to 67.0% (911/1,359) for a vaccine with 50% effectiveness. For a 95% effective vaccine, being a healthcare worker and having a higher perceived risk of COVID-19 infection were associated with higher acceptance, adjusted odds ratio (aOR): 2.01; 95%CI: 1.01, 4.00 and aOR: 2.21; 95%CI: 1.07, 4.59, respectively; compared to civil servants, being retired was associated with less acceptance (aOR: 0.15; 95%CI: 0.04, 0.63). For a 50% effective vaccine, being a healthcare worker was also associated with greater acceptance, aOR: 1.57; 95%CI: 1.12, 2.20. Conclusion: Acceptance of a COVID-19 vaccine was highly influenced by the baseline effectiveness of the vaccine. Preparing the general population to accept a vaccine with relatively low effectiveness may be difficult.

show abstract

Section: Discussionmentioning

confidence: 88%

Section: Discussionmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia

Harapan

Wagner

Yufika

et al. 2020

Front. Public Health

Self Cite

578

558

View full text Add to dashboard Cite

show abstract

“…Compared to previous studies conducted in Malaysia, the WTP for the hypothetical COVID-19 vaccine found in this study is over three-fold higher than the WTP for a hypothetical dengue vaccine (MYR39.21 [USD 9.45 USD] per dose) 19 and the hepatitis B vaccination (MYR$303 [USD 73 USD] per three-dose series). 20 To date, no studies have been conducted on the WTP of influenza vaccine in Malaysia. In Malaysia, influenza vaccination is not mandatory.…”

Section: Discussionmentioning

confidence: 99%

The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay

Wong

Alias

Lee

et al. 2020

Human Vaccines & Immunotherapeutics

688

116

763

View full text Add to dashboard Cite

Background: The development of a vaccine against SARS-CoV-2 infection is on the way. To prepare for public availability, the acceptability of a hypothetical COVID-19 vaccine and willingness to pay (WTP) were assessed to provide insights into future demand forecasts and pricing considerations. Methods: A cross-sectional survey was conducted from 3 to 12 April 2020. The health belief model (HBM) was used to assess predictors of the intent to receive the vaccine and the WTP. Results: A total of 1,159 complete responses was received. The majority reported a definite intent to receive the vaccine (48.2%), followed by a probable intent (29.8%) and a possible intent (16.3%). Both items under the perceived benefits construct in the HBM, namely believe the vaccination decreases the chance of infection (OR = 2.51, 95% CI 1.19-5.26) and the vaccination makes them feel less worry (OR = 2.19, 95% CI 1.03-4.65), were found to have the highest significant odds of a definite intention to take the vaccine. The mean ± standard deviation (SD) for the amount that participants were willing to pay for a dose of COVID-19

show abstract

“…Though limited evidences are available on health professionals’ WTP for HBV vaccination, evidences are available on WTP for vaccinations against other viruses such as Dengue virus, Tick-borne Encephalitis virus, Influenza virus, and Zika virus. These evidences show that sex, age, marital status, educational status, occupation, monthly income, residence, knowledge and attitude towards the vaccine, time consumed, perceived risk, disease related knowledge, severity of the disease, peer pressure, and medical advice are factors associated with willing to pay for vaccination [21–26].…”

Section: Introductionmentioning

confidence: 99%

Health professionals’ acceptance and willingness to pay for hepatitis B virus vaccination in Gondar City Administration governmental health institutions, Northwest Ethiopia

Abiye

Yitayal

Abere

et al. 2019

BMC Health Serv Res

View full text Add to dashboard Cite

BackgroundHepatitis B virus (HBV) infection is a global public health problem. The burden of the disease is high in low and middle income countries like Ethiopia. However, for highly vulnerable groups such as health professionals, vaccination coverage is a major issue in the developing countries where health professionals are expected to pay for vaccination. Therefore, the objective of this study was to assess health professionals’ acceptance and willingness to pay (WTP) and associated factors for vaccination against HBV.MethodsCross-sectional study was conducted from March to April, 2017 in Gondar city administration governmental health institutions among 423 health professionals. Simple random sampling method was employed to select the study participants. Data were collected using self- administered questionnaire. Tobit model was used to analyze the determinants of WTP and the maximum amount of money the individuals might pay for HBV vaccination. P-value < 0.05 was considered statistically significant.ResultA total of 423 health professionals (physicians, nurses, midwives, laboratory technicians/technologists, and others) participated in the study with a response rate of 100, and 62.4% of them were willing to pay for HBV vaccination. The mean amount of money the participants might pay for HBV vaccination was 325.83 ± 283.46 ETB (US$ 14.39 ± 12.52). The study indicated that the WTP for HBV vaccination of health professionals from health centers was 179.41 ETB less compared to health professionals from hospital. The WTP for HBV vaccination of the participants who had no experience of seeing previous patients with HBV was 157.87 ETB less compared to participants who had experience of seeing previous patients with HBV. As monthly income of the study participants increased by one ETB, the WTP was increased by 0.027 ETB.ConclusionThe study revealed that the mean amount of money the participants might pay for HBV vaccination was much less than the market price for HBV vaccination. Type of workplace and experience of seeing/observing patients with HBV, and income were the predictors of WTP for HBV vaccination. Availing the vaccine with affordable cost in governmental health institutions may increase WTP of health professionals for HBV vaccination.

show abstract

Willingness to pay for hepatitis B vaccination in Selangor, Malaysia: A cross-sectional household survey

Cited by 52 publications

References 62 publications

Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia

Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia

The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay

Health professionals’ acceptance and willingness to pay for hepatitis B virus vaccination in Gondar City Administration governmental health institutions, Northwest Ethiopia

Contact Info

Product

Resources

About